IP Forecast: Novartis To Fight Antitrust Row Over Drug Patent
Novartis is set to oppose an appeal at the Second Circuit from a rival seeking to restore an antitrust suit accusing it of hiding things from the patent office to illegally...To view the full article, register now.
Already a subscriber? Click here to view full article